Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Berberine induces double-strand DNA breaks in Rev3 deficient cells

  • Authors:
    • Xiaojuan Hu
    • Xiaohua Wu
    • Yunfei Huang
    • Qingyi Tong
    • Shunichi Takeda
    • Yong Qing
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacology, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Regenerative Medicine Research Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan 610041, P.R. China, Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
  • Pages: 1883-1888
    |
    Published online on: February 28, 2014
       https://doi.org/10.3892/mmr.2014.1999
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Berberine is a natural isoquinoline alkaloid, the majority of which is extracted from Huang Lian and other medicinal herbs. Numerous studies have revealed that berberine exhibits anticancer activity, however the mechanisms underlying this effect remain elusive. To examine these mechanisms, we analyzed the effects of berberine on a panel of DNA repair deficient chicken B lymphocyte (DT40) clones. Our results revealed that DT40 cells deficient in Rev3 (Rev3-/-), a translesion DNA synthesis (TLS) gene, were hypersensitive to berberine. Following berberine treatment, cell cycle analysis identified that G2/M arrest was increased in Rev3-/- cells. Furthermore, compared with wild-type cells (WT), berberine also induced a significant increase in double-strand breaks (DSBs) in Rev3-/- cells, as revealed by chromosomal aberration (CA) analysis. These results suggest that berberine is able to induce DNA damage, and that the Rev3 associated DNA repair pathway participates in the processes that aid its repair.

Introduction

Berberine is the major active component of the Chinese herbal medicine Huang Lian (1), which has been widely used clinically as a natural microbial agent in the treatment of diseases like dysentery and gastroenteritis (2,3). In recent years, a number of studies have reported that berberine has antitumor effects on numerous cancer cell line types, including leukocyte, glioblastoma, esophageal, breast and osteosarcoma (4–8). The anticancer mechanisms of berberine appear to be complex: Certain studies have suggested that berberine may interfere with DNA replication, acting as an inhibitor of replication and repair enzymes (6), while others have implied it may induce DNA damage directly (9). In addition, it has been reported that berberine is capable of inducing apoptosis through DNA damage-independent signaling pathways, including fatty acid synthase (Fas) receptor and estrogen receptor (10,11).

As high doses of berberine provoke a wide variety of cellular responses, the mechanisms that explain its genotoxicity remain difficult to define. Rev3, a catalytic subunit of DNA polymerases ζ (Polζ), participates in translesion DNA synthesis (TLS) and has been identified as an important component in the maintenance of chromosomal DNA, in its ability to enhance tolerance to DNA damage (12). Previously, we generated Rev3 deficient DNA repair deficient chicken B lymphocyte (DT40) cells (Rev3−/−) and identified they were hypersensitive to various DNA damaging agents, including IR, cisplatin and UV (13,14). Besides their specific sensitivity, Rev3−/− cells also possess a number of advantages as DT40 clones. Firstly, the proliferation of DT40 clones with a cell cycle time of 8 h is more rapid than that of the majority of mammalian cell lines. Secondly, during logarithmic growth, 70% of DT40 cells are in S phase, in contrast to the 50% for mammalian cells, so that exogenous DNA damage may target DNA replication directly. Finally, due to the absence of functional p53, DT40 cells lack the G1/S checkpoint. Therefore, DNA repair activity contributes a greater extent to cell survival, which aids our observations of the chromosomal breaks in mitotic cells, as cells carrying double-strand breaks (DSBs) can enter the M phase without stimulating the apoptosis pathway (15). As a result, Rev3−/− cells have been characterized as an excellent tool for studying the DNA damage and repair mechanisms of different chemicals, including tamoxifen and nitric oxide (NO) (11,16).

In the present study, we used Rev3−/− and other DNA repair gene deficient cells to study the mechanisms of berberine. We identified that Rev3−/− and several other DNA repair gene deficient clones including Rev1−/−, Parp1−/−, Rad18−/−, Xrcc2−/−, were hypersensitive to the naturally occurring alkaloid. Cell cycle and chromosomal break analysis demonstrated that berberine induced a significant increase in G2/M phase cells and chromosomal breaks in Rev3−/−, compared with the wild-type (WT) cells. These results suggest that berberine is able to directly induce DNA damage, and that Rev3 participates in the processes that aid its repair.

Materials and methods

Chemicals

The berberine chloride and alachlor was obtained from Sigma-Aldrich (St. Louis, MO, USA). Stock solution of berberine (20 mM) was prepared in DMSO and stored at −20°C in aliquots until use.

Cell line and cell culture

The cells were cultured as described previously (17,18). The cell lines used in this study are listed in Table I. The phenotypes of these cells have been previously described (12,19–25). The WT cell line and the DNA repair-deficient cell lines differ only in the presence/absence of an endogenous DNA repair gene, other than this difference, their genetic backgrounds were identical (15). All cell lines were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 1% chicken serum, 0.1% β mercaptoethanol and 1% penicillin. The cell lines were maintained at 39°C under a humidified atmosphere and 5% CO2. The study was approved by the Ethics Committee of Sichuan University (Chengdu, China).

Table I

DNA repair genes mutated in the analyzed DT40 clones.

Table I

DNA repair genes mutated in the analyzed DT40 clones.

GeneFunctionReference
Rev3TLS, catalytic subunit of Polζ12
Rev1TLS, deoxycytidyl transferase activity19
Rad18TLS20
PARP1Poly(ADP) ribosylation, related to single-strand and base excision repair21
XPAAn initial step of nucleotide excision repair20
DNA-PKcsNonhomologous end-joining-dependent double-strand break repair, the catalytic subunit of DNA-dependent protein kinase22
Ku70Initial step of nonhomologous end-joining-dependent double-strand break repair, associated with DNA-PK catalytic subunit19
Rad52Homologous recombination23
Xrcc2Rad51 paralog, homologous recombination, promotion of Rad51 assembly24
Brca1Homologous recombination23
Brca2Homologous recombination25

[i] Pol, polymerase; TLS, translesion DNA synthesis.

Measurement of cell proliferation by ATP assay

To assess cell numbers following treatment with berberine, we measured the amount of ATP in the whole cell lysate (26). Cells (1.5×103–1.5×104) were incubated in 1 ml culture medium per well, containing various concentrations of berberine. At 72 h, the ATP in the cellular lysates was measured to assess the number of live cells. At least three independent experiments were conducted. Sensitivity was calculated by dividing the number of drug-treated cells, by the number of untreated cells (13).

Cell-cycle analysis

Following treatment with 5 μM berberine for 16 h, cells were labeled for 10 min with 20 μM Bromodeoxyuridine (BrdU) and subsequently harvested. Harvested cells were fixed and analyzed as previously described (19): (i) In 4N HCl, 0.5% Triton X-100 for 30 min at room temperature; (ii) in FITC-conjugated anti-BrdU antibody for 1 h at room temperature; (iii) in 5 μg/ml propidium iodide (PI) in PBS. Following incubation, cells were washed with PBS containing 2% FCS and 0.1% sodium azide. Subsequent flow cytometric analysis was performed on a FACScan. Fluorescence data were displayed as dot plots using the Cell Quests software.

Chromosomal aberration (CA) analysis

Measurement of CA was performed as previously described (12). The chicken karyotype consisted of 80 chromosomes, including 11 major autosomal macrochromosomes, the ZW sex chromosomes, and 67 microchromosomes (15). In the present study, only the 11 major autosomal macrochromosomes were measured. For CA analysis, cells (3.0×106/3 ml) were treated with the test doses of 2.5 and 5 μM for berberine and 5 μM for alachlor for 16 h. Then cells were treated for 30 min with 0.1 μg/ml colcemid and went on harvesting for 2.5 h. We then suspended the cells with 75 mM KCL and incubated them for 15 min at room temperature, adding 5 ml of Carnoy’s solution (mixture of acetic acid and methanol, 1:3) and left for at least 30 min at room temperature. The cells were then dropped onto ethanol-cleaned slides and dried by a flame. The dried slide was then dipped into 5% Giemsa solution, left for 8 min at room temperature and rinsed carefully with water and finally, they were air-dried. The cells were observed under a light microscope (magnification, ×1,000).

Statistical analysis

Survival data were log-transformed giving approximate normality. Analysis of covariance (ANCOVA) was used to test for differences in the linear dose-response curves between WT and a series of mutant cells. Viability of the DT40 cells was estimated using regression curves. Regression-curve equations were used to calculate LC50 (lethal concentration, 50%) values. Relative LC50 values were normalized according to the LC50 value of the parental WT cells.

Results

Rev3−/− cells are sensitive to berberine

As Rev3−/− are specifically sensitive to a variety of DNA damaging agents, in the present study we assessed whether Rev3−/− cells exhibit a higher sensitivity to berberine. We treated WT and Rev3−/− cells with varying concentrations of berberine for 72 h, and measured the viability of cells using an ATP assay. As summarized in Fig. 1, Rev3−/− cells exhibited a significant increase in sensitivity to berberine when compared with WT cells. This observation indicated that berberine may induce DNA damage, and that Rev3 associated DNA repair is an important regulatory process in cellular tolerance to berberine-induced genotoxicity. To study whether other DNA repair pathways were also involved in tolerance to berberine, we assessed the sensitivity of berberine in a panel of DT40 clones, which were separately deficient in different DNA repair pathways (Table I). The DNA repair pathway mutants demonstrated sensitivity to berberine in the following order: Rev3 > Rev1 > Parp1 = Xrcc2 = Rad18 > WT (parental DT40 cells)

Figure 1

Cellular tolerance to berberine. (A) Cells of the indicated genotype were exposed to berberine for 72 h, a period during which WT cells were able to divide nine times in the absence of exogenous DNA damage. The x-axis represents the concentration of berberine and the y-axis represents the relative number of surviving cells at 72 h. (B) Relative LC50 values of berberine. Values shown are the mean ± SD. WT, wild-type; LC50, the concentration of berberine that reduces cellular survival to 50% relative to cellular survival without berberine treatment.

Berberine induces enhanced arrest of cell cycle in G2/M phase

As DT40 cells are deficient in p53, and agents causing DNA damage would lead to cell arrest in G2/M phase, we assessed if the increased sensitivity of Rev3−/− to berberine was also correlated with G2/M arrest. Data from the pulse labeled with BrdU indicated that berberine induced an increase in the accumulation of Rev3−/− cells in the G2/M phase compared with that in the WT cells (Fig. 2).

Figure 2

Representative cell-cycle distribution of the indicated cell cultures as measured by pulse BrdU incorporation and DNA content in flow cytometric analysis. Cell-cycle distribution of berberine treated cells that were pulse labeled with BrdU for 10 min and subsequently stained with FITC-conjugated anti-BrdU antibody (y-axis, log scale) and PI (x-axis, linear scale). The upper gate indicates cells incorporating BrdU (S phase), the lower middle gate indicates G1 cells and the lower-right gate indicates G2/M cells. The sub G1 fraction (lower-left gate) indicates dead cells. The number in each gate indicates the percentage of gated events. The berberine pretreatment time is 16 h. PI, propidium iodide; WT, wild-type; Rev3−/−, Rev3 deficient DT40; BrdU, bromodeoxyuridine.

Berberine induces an increase of chromosome breaks in Rev3−/− cells

To examine if the higher sensitivity of Rev3−/− to berberine was specifically associated with DNA damage, we measured the number of chromosome breaks in mitotic cells. Fifteen CAs were detectable in 50 mitotic Rev3−/− cells when the concentration of berberine was 2.5 μM, while only 4 CAs were identified in WT cells. As the concentration elevated to 5 μM, the CAs in Rev3−/− cells markedly increased to 23, by contrast, WT cells showed fewer aberrations of only 7 (Table II and Fig. 3). This result was consistent with the positive control, alachlor. The data suggest that the hypersensitivity of Rev3−/− to berberine is correlated with a significant increase of berberine-induced CAs.

Figure 3

Representative karyotype analysis of berberine and alachlor pretreated Rev3-deficient cells. (A) CAs in Rev3−/− cells following 5 μM berberine pretreatment for 16 h. (B) CAs in Rev3−/− cells following 5 μM alachlor pretreatment for 16 h. Macrochromosomes 1–5 and Z are identified. Chromatid breaks are shown by arrows and gaps are shown by arrowheads, respectively. Exchanges are shown by crude arrows. CA, chromosome aberration; Rev3−/−, Rev3 deficient DT40.

Table II

Frequencies of chromosomal aberrations in WT and Rev3 deficient DT40 cells.

Table II

Frequencies of chromosomal aberrations in WT and Rev3 deficient DT40 cells.

ChromatidIsochromatid


CellTreatmentGapsBreaksGapsBreaksExchangeTotal
WT-020002
WTBerberine (2.5 μm)020114
WTBerberine (5 μm)131117
WTAlachlor (5 μm)01312218
Rev3−/−-111104
Rev3−/−Berberine (2.5 μm)1912215
Rev3−/−Berberine (5 μm)11722123
Rev3−/−Alachlor (5 μm)03542546

[i] The data represent the numbers of aberrations per 50 cells. At least 50 mitotic cells were analyzed for each genotype. The pretreatment time is 16 h. WT, wild-type; Rev3−/−, Rev3 deficient DT40.

Discussion

In the present study, we utilized a panel of DNA repair deficient DT40 cells to study the genotoxicity mechanisms of the natural alkaloid, berberine. Our results demonstrated that cells deficient in Rev3 exhibited the highest sensitivity to berberine. The cell cycle and chromosome breaks assay provided evidence that more G2/M arrest and chromosome breaks occurred in Rev3−/− cells than in WT cells. While the Rev−/− cells were the most sensitive, the other DNA repair gene deficient cells, including Rev1−/−, Parp1−/−, Rad18−/− and Xrcc2−/− cells were also sensitive to berberine, but polβ−/−, XPA−/−, DNA-PK−/− cells were not. Two important homologous recombination (HR) enzymes, Brca1 and Brca2, were slightly resistant to berberine. These results provided clear evidence that berberine is able to induce DNA damages, and that Rev3 as well as Rev1, Rad18, Parp1 and Xrcc2 are important in processes that repair these damages.

Rev3 is a catalytic subunit of Polζ. Studies in yeast have revealed that Polζ cells are able to efficiently bypass abasic sites, through extending from nucleotides inserted opposite the lesion, by other TLS DNA polymerases. These data suggest Polζ may be involved in the extension process of TLS in higher eukaryotes (27). One reverse genetics study in DT40 cells identified that Rev3 participated in not only TLS but also HR (12). Rev1 and Rad18 appear to have a similar function to Rev3 in maintaining genomic stability by TLS and HR (19). The high sensitivity of Rev3−/−, Rev1−/− and Rad18−/− to berberine implies that TLS or HR may participate in berberine-induced DNA damage. TLS and HR are two major pathways that promote survival following post-replication DNA damage (28,29). HR accurately repairs DSBs that arise during the mitotic cell cycle or those induced by radiotherapy (30,31). This process also releases replication forks that stall at damaged template DNA strands, by using intact sister chromatids as a template (32,33). The function of TLS is to release stalled replication forks by filling gaps on daughter strands that remain, following DNA replication caused by damage on the mother strand (34). Although cells deficient in Brca1 or Brca2, were not sensitive but slightly resistant to berberine, cells deficient in Xrcc2, a RAD51 paralog in HR (35), did exhibit sensitivity to berberine. Parp1 regulates several processes of DNA repair and also participates in HR. The sensitivity of Parp1−/− and Xrcc2−/− cells to berberine suggested that HR may participate in berberine-induced DNA repair. The importance of HR in repairing berberine-induced DNA damage has also been proved in yeast (9). Earlier studies have demonstrated that Brca1−/− and Brca2−/− cells were highly sensitive to several chemotherapeutic agents including cisplatin, camptothecin and olaparib, which separately stalled DNA replicative polymerases, via the formation of intra- and inter-strand crosslinks, inhibition of topoisomerase I and inhibition of Parp1 (36). In addition, previous studies have shown that Rad18−/− rather than Rev3−/− was more sensitive to camptothecin (37). These differences imply that the anticancer mechanisms of berberine are different from the aforementioned chemotherapeutic agents, although all of them are able to induce DSBs and HR repair. These results present that there are different DNA damage mechanisms between berberine and these agents, although certain studies considered that berberine may function as a topoisomerase I inhibitor like camptothecin (38).

Acknowledgements

This study was mainly supported by the Administration of Traditional Chinese Medicine of Sichuan Province, China.

References

1 

Yin J, Ye JP and Jia WP: Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica Sin B. 2:327–334. 2012. View Article : Google Scholar

2 

Takase H, Yamamoto K, Ito K and Yumioka E: Pharmacological studies on antidiarrheal effects of berberine and geranii herba. Nihon Yakurigaku Zasshi. 102:101–112. 1993.(In Japanese).

3 

Lin JP, Yang JS, Lee JH, Hsieh WT and Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol. 12:21–28. 2006.PubMed/NCBI

4 

Lin CC, Kao ST, Chen GW, Ho HC and Chung JG: Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res. 26:227–242. 2006.PubMed/NCBI

5 

Sanders MM, Liu AA, Li TK, Wu HY, Desai SD, Mao Y, Rubin EH, LaVoie EJ, Makhey D and Liu LF: Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochem Pharmacol. 56:1157–1166. 1998. View Article : Google Scholar : PubMed/NCBI

6 

Liu Q, Jiang H, Liu Z, Wang Y, Zhao M, Hao C, Feng S, Guo H, Xu B, Yang Q, et al: Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS ONE. 6:e234272011. View Article : Google Scholar

7 

Wang J, Liu Q and Yang QF: Radiosensitization effects of berberine on human breast cancer cells. Int J Mol Med. 30:1166–1172. 2012.PubMed/NCBI

8 

Liu ZJ, Liu Q, Xu B, Wu JJ, Guo C, Zhu FL, Yang QZ, Gao GM, Gong YQ and Shao CS: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res. 662:75–83. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Pasqual MS, Lauer CP, Moyna P and Henriques JAP: Genotoxicity of the isoquinoline alkaloid berberine in prokaryotic and eukaryotic organisms. Mutat Res. 286:243–252. 1993. View Article : Google Scholar : PubMed/NCBI

10 

Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, Hsia TC, Liao CL, Lin JG, Wood WG and Chung JG: Berberine induced apoptosis via promoting the expression of caspase-8, −9 and −3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 29:4063–4070. 2009.PubMed/NCBI

11 

Mizutani A, Okada T, Shibutani S, Sonoda E, Hochegger H, Nishigori C, Miyachi Y, Takeda S and Yamazoe M: Extensive chromosomal breaks are induced by tamoxifen and estrogen in DNA repair-deficient cells. Cancer Res. 64:3144–3147. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Sonoda E, Okada T, Zhao GY, Tateishi S, Araki K, Yamaizumi M, Yagi T, Verkaik NS, van Gent DC, Takata M and Takeda S: Multiple roles of Rev3, the catalytic subunit of polζ in maintaining genome stability in vertebrates. EMBO J. 22:3188–3197. 2003.

13 

Nojima K, Hochegger H, Saberi A, Fukushima T, Kikuchi K, Yoshimura M, Orelli BJ, Bishop DK, Hirano S, Ohzeki M, Ishiai M, et al: Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65:11704–11711. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Takezawa J, Aiba N, Kajiwara K and Yamada K: Caffeine abolishes the ultraviolet-induced REV3 translesion replication pathway in mouse cells. Int J Mol Sci. 12:8513–8529. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Yamamoto KN, Hirota K, Kono K, Takeda S, Sakamuru S, Xia M, Huang R, Austin CP, Witt KL and Tice RR: Characterization of environmental chemicals with potential for DNA damage using isogenic DNA repair-deficient chicken DT40 cell lines. Environ Mol Mutagen. 52:547–561. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Wu XH, Takenaka K, Sonoda E, Hochegger H, Kawanishi S, Kawamoto T, Takeda S and Yamazoe M: Critical roles for polymeraseζ in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res. 66:748–754. 2006.

17 

Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y and Takeda S: Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:598–608. 1998. View Article : Google Scholar : PubMed/NCBI

18 

Buerstedde JM and Takeda S: Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell. 67:179–188. 1991. View Article : Google Scholar : PubMed/NCBI

19 

Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A and Takeda S: Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:5497–5508. 1998. View Article : Google Scholar : PubMed/NCBI

20 

Okada T, Sonoda E, Yamashita YM, Koyoshi S, Tateishi S, Yamaizumi M, Takata M, Ogawa O and Takeda S: Involvement of vertebrate polkappa in Rad18-independent postreplication repair of UV damage. J Biol Chem. 277:48690–48695. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Hossain MB, Ji P, Anish R, Jacobson RH and Takada S: Poly(ADP-ribose) Polymerase 1 interacts with nuclear respiratory factor 1 (NRF-1) and plays a role in NRF-1 transcriptional regulation. J Biol Chem. 284:8621–8632. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Fukushima T: Genetic analysis of the DNA-dependent protein kinase reveals an inhibitory role of Ku in late S-G2 phase DNA Double-strand break repair. J Biol Chem. 276:44413–44418. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Qing Y, Yamazoe M, Hirota K, Dejsuphong D, Sakai W, Yamamoto KN, Bishop DK, Wu X and Takeda S: The epistatic relationship between BRCA2 and the other RAD51 mediators in homologous recombination. PLoS Genet. 7:e10021482011. View Article : Google Scholar : PubMed/NCBI

24 

Danoy P, Sonoda E, Lathrop M, Takeda S and Matsuda F: A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage. Biochem Biophys Res Commun. 352:763–768. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Hatanaka A, Yamazoe M, Sale JE, Takata M, Yamamoto K, Kitao H, Sonoda E, Kikuchi K, Yonetani Y and Takeda S: Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V Gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination. Mol Cell Biol. 25:1124–1134. 2005. View Article : Google Scholar

26 

Ji K, Kogame T, Choi K, Wang X, Lee JY, Taniguchi Y and Takeda S: A novel approach using DNA-repair-defcient chicken DT40 cell lines for screening and characterizing the genotoxicity of environmental contaminants. Environ Health Perspect. 117:1737–1744. 2009.PubMed/NCBI

27 

Haracska L, Unk I, Johnson RE, Johansson E, Burgers PM, Prakash S and Prakash L: Roles of yeast DNA polymerasesδ and ζ and of Rev1 in the bypass of abasic sites. Genes Dev. 15:945–954. 2001.

28 

Hochegger H, Sonoda E and Takeda S: Post-replication repair in DT40 cells: translesion polymerases versus recombinases. Bioessays. 26:151–158. 2004. View Article : Google Scholar : PubMed/NCBI

29 

van Gent DC, Hoeijmakers JH and Kanaar R: Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet. 2:196–206. 2001.

30 

Sharma S, Hicks JK, Chute CL, Brennan JR, Ahn JY, Glover TW and Canman CE: REV1 and polymeraseζ facilitate homologous recombination repair. Nucleic Acids Res. 40:682–691. 2012.

31 

Venkitaraman AR: Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol. 4:461–487. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Yamazoe M, Sonoda E, Hochegger H and Takeda S: Reverse genetic studies of the DNA damage response in the chicken B lymphocyte line DT40. DNA Repair (Amst). 3:1175–1185. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Branzei D, Vanoli F and Foiani M: SUMOylation regulates Rad18-mediated template switch. Nature. 456:915–920. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Friedberg E, Lehmann A and Fuchs R: Trading places: How do DNA polymerases switch during translesion DNA synthesis? Mol Cell. 18:499–505. 2005. View Article : Google Scholar : PubMed/NCBI

35 

Murakawa Y, Sonoda E, Barber LJ, Zeng W, Yokomori K, Kimura H, Niimi A, Lehmann A, Zhao GY, Hochegger H, et al: Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells. Cancer Res. 67:8536–8543. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Bhat A, Andersen PL, Qin Z and Xiao W: Rev3, the catalytic subunit of Polζ, is required for maintaining fragile site stability in human cells. Nucleic Acids Res. 41:2328–2339. 2013.

37 

Yoshimura A, Nishino K, Takezawa J, Tada S, Kobayashi T, Sonoda E, Kawamoto T, Takeda S, Ishii Y, Yamada K, Enomoto T and Seki M: A novel Rad18 function involved in protection of the vertebrate genome after exposure to camptothecin. DNA Repair (Amst). 5:1307–1316. 2006. View Article : Google Scholar : PubMed/NCBI

38 

Tomicic MT and Kaina B: Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors. Biochim Biophys Acta. 1835:11–27. 2013.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu X, Wu X, Huang Y, Tong Q, Takeda S and Qing Y: Berberine induces double-strand DNA breaks in Rev3 deficient cells. Mol Med Rep 9: 1883-1888, 2014.
APA
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., & Qing, Y. (2014). Berberine induces double-strand DNA breaks in Rev3 deficient cells. Molecular Medicine Reports, 9, 1883-1888. https://doi.org/10.3892/mmr.2014.1999
MLA
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., Qing, Y."Berberine induces double-strand DNA breaks in Rev3 deficient cells". Molecular Medicine Reports 9.5 (2014): 1883-1888.
Chicago
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., Qing, Y."Berberine induces double-strand DNA breaks in Rev3 deficient cells". Molecular Medicine Reports 9, no. 5 (2014): 1883-1888. https://doi.org/10.3892/mmr.2014.1999
Copy and paste a formatted citation
x
Spandidos Publications style
Hu X, Wu X, Huang Y, Tong Q, Takeda S and Qing Y: Berberine induces double-strand DNA breaks in Rev3 deficient cells. Mol Med Rep 9: 1883-1888, 2014.
APA
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., & Qing, Y. (2014). Berberine induces double-strand DNA breaks in Rev3 deficient cells. Molecular Medicine Reports, 9, 1883-1888. https://doi.org/10.3892/mmr.2014.1999
MLA
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., Qing, Y."Berberine induces double-strand DNA breaks in Rev3 deficient cells". Molecular Medicine Reports 9.5 (2014): 1883-1888.
Chicago
Hu, X., Wu, X., Huang, Y., Tong, Q., Takeda, S., Qing, Y."Berberine induces double-strand DNA breaks in Rev3 deficient cells". Molecular Medicine Reports 9, no. 5 (2014): 1883-1888. https://doi.org/10.3892/mmr.2014.1999
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team